Antibiotic Innovation Race explores the escalating crisis of antibiotic resistance (AMR), a major threat to global public health. The book examines how bacteria evolve resistance, rendering once-effective treatments useless, and highlights the economic disincentives hindering new antibiotic development. It also investigates the regulatory hurdles slowing innovation, emphasizing the need for a multifaceted approach to combat infectious diseases and ensure responsible antibiotic use. Did you know that the golden age of antibiotic discovery in the mid-20th century led to widespread use, inadvertently fueling the rise of drug resistance? The book uniquely integrates scientific, economic, and policy perspectives, moving beyond problem identification to propose concrete solutions for antibiotic innovation. Beginning with microbiology basics, it progresses through the development of resistance, economic barriers, and regulatory landscapes. Later chapters spotlight innovative approaches and policy recommendations. By showcasing successful and unsuccessful antibiotic programs and using data from organizations like WHO and CDC, the book provides a comprehensive understanding of the challenges and potential pathways forward in the race against AMR.
